2型糖尿病家族史延缓TEDDY研究中胰岛自身免疫儿童1型糖尿病的发展
TEDDY前瞻性队列纳入8676例高危HLA基因型新生儿,分析家族糖尿病史对胰岛自身免疫及1型糖尿病进展的影响。一级亲属1型糖尿病增加胰岛自身免疫风险(HR 2.2),而二级亲属2型糖尿病显著延缓从自身抗体阳性到1型糖尿病的进展(HR 0.61)。
要点
- 一级亲属1型糖尿病使胰岛自身免疫风险增加2.2倍。
- 二级亲属2型糖尿病延缓自身免疫向1型糖尿病进展(HR 0.61)。
- 其他类型糖尿病或自身免疫病家族史与结局无关。
核心结论
- 家族糖尿病史与胰岛自身免疫及1型糖尿病进展呈差异性关联。
研究设计与样本
- TEDDY前瞻性观察队列,2004-2010年芬兰、德国、瑞典、美国新生儿中纳入8676例高危HLA-DR-DQ基因型儿童。
主要发现
- 一级亲属1型糖尿病增加胰岛自身免疫风险(HR 2.2 [95%CI 1.8, 2.8];p<0.001)。
- 排除一级亲属1型糖尿病后,二级亲属1型糖尿病与胰岛自身免疫相关(HR 1.4 [95%CI 1.1, 1.8];p=0.017)。
- 二级亲属2型糖尿病延缓从自身抗体阳性到1型糖尿病进展(HR 0.61 [95%CI 0.44, 0.86];p=0.004)。
- 其他类型糖尿病或自身免疫病家族史与胰岛自身免疫或1型糖尿病进展无关。
临床怎么用
- 评估1型糖尿病高危儿童时,需区分一级与二级亲属糖尿病类型以细化风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aetiology of type 1 diabetes remains elusive. Family history of type 1 diabetes increases the disease risk but the role of other autoimmune diseases or type 2 diabetes in the family are unclear. Here, we aimed to analyse the effect of family history of diabetes and autoimmune diseases on development of islet autoimmunity and progression to type 1 diabetes. METHODS: The Environmental Determinants of Diabetes in the Young (TEDDY) study is a prospective observational cohort study of children recruited as newborns in 2004-2010 at clinical centres in Finland, Germany, Sweden and the USA. A total of 8676 children with high-risk HLA-DR-DQ genotype for type 1 diabetes fulfilled the eligibility criteria for regular follow-up. Questionnaire-based family history of all types of diabetes and autoimmune diseases among first- and second-degree relatives (FDRs and SDRs; data available for 8558 and 7479 children, respectively) was collected. The main outcomes were development of islet autoimmunity and progression from autoimmunity to type 1 diabetes. Data until 31 January 2016 were analysed. RESULTS: Persistent islet autoantibodies were found in 669 children and type 1 diabetes in 233 children (45% and 46% female sex, respectively). The median follow-up time after seroconversion was 6.5 years (IQR 3.3-8.5). Having an FDR with type 1 diabetes increased the child's risk of islet autoimmunity (HR 2.2 [95% CI 1.8, 2.8]; p<0.001), particularly if the father or sibling had type 1 diabetes. Islet autoimmunity was also associated with family history of type 1 diabetes in an SDR when participants having an FDR with type 1 diabetes were excluded from the analysis (HR 1.4 [95% CI 1.1, 1.8]; p=0.017). Notably, progression from autoantibody positivity to type 1 diabetes was significantly delayed in children having type 2 diabetes in an SDR (HR 0.61 [95% CI 0.44, 0.86]; p=0.004). Islet autoimmunity or progression to type 1 diabetes were not associated with other types of diabetes or autoimmune diseases in the family. CONCLUSIONS/INTERPRETATION: Family history of diabetes is differentially associated with development of islet autoimmunity and progression to type 1 diabetes. The contribution made by familial, genetic and environmental factors to the two phases of the disease pathogenesis deserves distinct analyses. DATA AVAILABILITY: Data reported here can be obtained by request at the NIDDK Central Repository website, Resources for Research (R4R), https://repository.niddk.nih.gov/ .
引用
- Veijola R, Tamura RN, Clasen JL, et al. Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity. Diabetologia. 2025. PMID: 41359174. doi:10.1007/s00125-025-06613-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。